A.D. Beadell Investment Counsel’s AbbVie ABBV Stock Holding History

A.D. Beadell Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-36,395	Closed	-$2.64M	–	89
2017 Q2	$2.64M	Hold	36,395	–	–	2.14%	10
2017 Q1	$2.37M	Sell	36,395 -1,200	-3%	-$75.4K	1.97%	12
2016 Q4	$2.35M	Sell	37,595 -1,075	-3%	-$65.6K	2.02%	11
2016 Q3	$2.44M	Sell	38,670 -200	-0.5%	-$12.9K	2.03%	10
2016 Q2	$2.41M	Hold	38,870	–	–	1.97%	12
2016 Q1	$2.22M	Buy	38,870 +3,522	+10%	+$196K	2.04%	13
2015 Q4	$2.09M	Buy	35,348 +13,910	+65%	+$801K	1.83%	12
2015 Q3	$1.17M	Buy	21,438 +8,600	+67%	+$560K	1.05%	37
2015 Q2	$862K	Buy	12,838 +433	+3%	+$28.3K	0.69%	51
2015 Q1	$726K	Buy	+12,405	New	+$749K	0.56%	59
2014 Q1	–	Sell	-12,700	Closed	-$670K	–	89
2013 Q4	$670K	Sell	12,700 -14,330	-53%	-$704K	0.57%	61
2013 Q3	$1.21M	Sell	27,030 -400	-1%	-$17.7K	1.09%	35
2013 Q2	$1.13M	Buy	+27,430	New	+$1.2M	1.04%	36

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

A.D. Beadell Investment Counsel's ABBV Position: Q3 2017 in Review

A.D. Beadell Investment Counsel sold out of AbbVie (ABBV) in Q3 2017, closing a stake of 36,395 shares — an estimated $2.64M sold.

A.D. Beadell Investment Counsel first reported a position in ABBV in Q2 2013 and held it in 13 quarters. The position peaked at $2.64M in Q2 2017. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

A.D. Beadell Investment Counsel reported no remaining AbbVie position as of Q3 2017 after selling out during the quarter.
A.D. Beadell Investment Counsel sold 36,395 AbbVie shares in Q3 2017, an estimated $2.64M.
A.D. Beadell Investment Counsel first reported a position in AbbVie in Q2 2013 and held it in 13 quarters.
A.D. Beadell Investment Counsel's AbbVie position peaked at $2.64M in Q2 2017.
1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on A.D. Beadell Investment Counsel's 13F filing for Q3 2017, filed 25 Oct 2017.